Search results for "FDA update"
Abbot FreeStyle Insulinx meters recalled
The Abbott FreeStyle Insulinx blood glucose meters were recently recalled because at extremely high blood glucose levels of 1,024 mg/dL and above, the meters will display and store in memory an incorrect test result that is 1,024 mg/dL below the measured result.
https://diabetes.acponline.org/archives/2013/07/12/9.htm
12 Jul 2013
First drug in new class approved
The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and exercise.
https://diabetes.acponline.org/archives/2013/06/14/10.htm
14 Jun 2013
Incretin mimetics' effects on pancreas under investigation
The FDA is investigating reports of possible increased risk of pancreatitis and precancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes.
https://diabetes.acponline.org/archives/2013/05/10/13.htm
10 May 2013
Single and combo diabetes drugs approved
Alogliptin (Nesina) and two new combination drugs (alogliptin and metformin hydrochloride [Kazano] and alogliptin and pioglitazone [Oseni]) were approved by the FDA to improve blood glucose control in adults with type 2 diabetes, along with diet and exercise.
https://diabetes.acponline.org/archives/2013/05/10/12.htm
10 May 2013
New drugs approved for diabetes
The first generic version of pioglitazone hydrochloride (Actos) and a new indication for ranibizumab injection (Lucentis) were recently announced by the FDA.
https://diabetes.acponline.org/archives/2012/11/09/9.htm
9 Nov 2012
Another weight loss drug approved
A combination of phentermine and topiramate extended-release (Qsymia) was recently approved by the FDA as an addition to a reduced-calorie diet and exercise for chronic weight management.
https://diabetes.acponline.org/archives/2012/10/12/10.htm
12 Oct 2012
New weight loss drug approved
Lorcaserin hydrochloride (Belviq) was recently approved by the FDA for chronic weight management in adults.
https://diabetes.acponline.org/archives/2012/09/14/10.htm
14 Sep 2012
New contraindication for aliskiren-containing medications
Aliskiren-containing medications are contraindicated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with diabetes.
https://diabetes.acponline.org/archives/2012/07/13/10.htm
13 Jul 2012